General
FDA panel votes against approving Intellipharma's opioid painkiller
 

FDA panel votes against approving Intellipharma's opioid painkiller

Shared by:

 
A panel of independent advisers to the U.S. Food and Drug Administration overwhelmingly concluded on Wednesday that there is not enough evidence to support approval of Intellipharmaceutics International Inc's long-acting opioid painkiller.
 
www.reuters.com
 
27 Jul 2017 - General